Mynvax

Efficacious vaccine for respiratory viruses

Bengaluru, India · Founded 2017 · $6.8M raised

Headquarters
Bengaluru
Employees
11–50
Founded
2017
Business Model
B2B
Website
mynvax.com
Total Funding
$6.8M
Last Round
$2.6M Series AMay 2024
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Mynvax is a pre-clinical stage vaccine biotechnology whose current develop programs include a recombinant vaccine for human influenza and COVID19. It focuses on an efficacious vaccine for respiratory viruses. Founded in 2017 and headquartered in Bangalore, Karnataka, Mynvax is privately held and works in biotechnology research.

Summary

Mynvax is a Biotech company based in Bengaluru, India, founded in 2017. It has raised $6.8M in total across 2 rounds, most recently a $2.6M Series A round in May 2024. Investors include Inviga Healthcare Fund, Accel and LetsVenture.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AMay 2024
$2.6M

Sign up to see all 2 events

Funding: Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Mynvax on Indexed.vc
<a href="https://indexed.vc/companies/mynvax"><img src="https://indexed.vc/api/badge/company/mynvax" alt="Mynvax on Indexed.vc" width="260" height="76" /></a>